A Long Island hospital has successfully treated Sebastien Beauzile, a 21-year-old from Laurelton, with the groundbreaking ...

A young man from Laurelton is the first New Yorker with sickle cell disease to receive Lyfgenia, a life-changing gene therapy treatment that has wiped away the debilitating illness, The Post first ...

A stem cell therapy trial aimed at reducing neuroinflammation in patients with presymptomatic Alzheimer's disease is underway at UTHealth Houston.

Sebastien Beauzile, 21, became the first person in New York state to be made symptom-free of sickle cell disease after ...

New research suggests restoring stellate cells to their healthy and protective state could simultaneously reduce liver scarring and improve liver function.

A patient on Long Island is the first in New York to be cured of sickle cell anemia, doctors say. They credit state-of-the-art genetic treatment. For 21 years, Sebastien Beauzile suffered chronic pain ...

Anyone living with sickle cell anemia is a warrior, Leslie Davis-Primo will tell you. “I’ve had three children, largely ...

A recently launched Phase 1 clinical trial is examining the safety and feasibility of a groundbreaking treatment approach for Parkinson's disease in which a patient's stem cells are reprogrammed to ...

A Shreveport-Bossier City musician is working tirelessly to better the quality of life for people like her sons, some of whom ae fighting a challenging disease.

POLG-related diseases disrupt the function of the mitochondria, or "powerhouses" of the cell — starving them of energy.

MS patients on anti-CD20 therapies are significantly less likely to discontinue treatment than those given other DMTs, a ...